The US Department of Health and Human Services has called for the Food and Drug Administration to improve its oversight of foreign clinical trial data after finding that sponsors rely “heavily” on such data to support their marketing applications and a lack of foreign trial inspections by the agency1...
Please login to read the full article.Welcome:
IBI01 - Circulation
scr
RAJ Pharma
US report finds flaws in FDA oversight of foreign clinical trials
23 June 2010
Vibha Sharma
RELATED CONTENT
NEWS
RAJ Pharma News
Other Informa News
ANALYSIS
Other Informa Analysis
EDITORIALS
Other Informa Editorials
FEATURES
RAJ Pharma Features
Other Informa Features
COUNTRY PROFILES
RAJ Pharma Country Profiles
Other Informa Country Profiles
COMMENT
RAJ Pharma Comment
Other Informa Comments
EVENTS
October 4th, 2010
London, UK
October 19th, 2010
Barcelona, Spain
October 20th, 2010
Barcelona, Spain